The Delft Bioinformatics Lab

Horlings HM, Lai C, Nuyten DS, Halfwerk H, Kristel P, van Beers EH, et al. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients. Clin Cancer Res. 2010;16(2):651-63.

Pramana J, van den Brekel MW, van Velthuysen M-, Wessels LF, Nuyten DS, Hofland I, et al. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. International Journal of Radiation Oncology, Biology, Physics. 2007;69:1544-52.

Fan C, Oh DS, Wessels LF, Weigelt B, Nuyten DS, Nobel AB, et al. Concordance among Gene-Expression–Based Predictors for Breast Cancer. The new england journal o f medicine. 2006;355:560-9.

Nuyten DS, Kreike B, Hart AA, Chi J-, Sneddon JB, Wessels LF, et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Research: BCR. 2006;8:R62.

Weigelt B, Wessels LF, Bosma AJ, Glas AM, Nuyten DS, He YD, et al. No common denominator for breast cancer lymph node metastasis. Britisch Journal of Cancer. 2005;93:924-32.